EKF Diagnostics Holdings plc of Penarth Cardiff at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

EKF Diagnostics Holdings plc

Avon House, 19 Stanwell Road,, CF64 2EZ Penarth Cardiff
United Kingdom of Great Britain and Northern Ireland
Telephone +44 2920 710570
Fax +44 2920 705715
info@ekfdiagnostics.com

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Hall map

MEDICA 2021 hall map (Hall 3): stand B71

Fairground map

MEDICA 2021 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.01  Clinical chemistry
  • 03.01.01  Glucose testing

Our products

Product category: Glucose testing

Biosen C-Line GP+

Biosen C-Line Glucose and Lactate analyzer

Up to 5 samples
Results in 20-45 seconds
Up to 120 results an hour
Imprecision < 1.5% CV
Size: 280 x 280 x 95 mm

More Less

Product category: Glucose testing

Biosen C-Line Clinic

Biosen C-Line Glucose and Lactate analyzer

Up to 20 samples
Results in 20-45 seconds
Up to 120 results an hour
Imprecision < 1.5% CV
Size: 280 x 280 x 95 mm

More Less

About us

Company portrait

EKF Diagnostics is a global medical manufacturer of point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose and lactate. EKF also has a long history in clinical chemistry reagent manufacture in the USA.

During the COVID-19 pandemic EKF began the production of PrimeStore MTM under licence from Longhorn Vaccines and Diagnostics in San Antonio, Texas. PrimeStore MTM is widely used in the US and Europe to neutralise viruses in patient samples.

EKF is also a distributor of the Kantaro COVID-SeroKlir antibody kits, a quantitative ELISA test. SeroKlir provides an antibody titer that determines the presence and volume of COVID-19 antibodies present in a patient.